Editorial comment on: Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells.
Schalken
Jack
J
D014408:Biomarkers, Tumor / Q000032:analysis; D045744:Cell Line, Tumor; D006801:Humans; D008297:Male; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000737:chemistry*; D014359:Trypsin Inhibitor, Kazal Pancreatic / Q000032:analysis*
D014408:Biomarkers, Tumor; D014359:Trypsin Inhibitor, Kazal Pancreatic